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The cystic fibrosis transmembrane conductance regulator
(CFTR, ABCC7), mutations of which cause cystic fibrosis,
belongs to the ATP-binding cassette (ABC) transporter family
and works as a channel for small anions, such as chloride and
bicarbonate. Anion channel activity is known to depend on
phosphorylation by cAMP-dependent protein kinase A (PKA)
and CFTR-ATPase activity.Whereas anion channel activity has
been extensively investigated, phosphorylation and CFTR-
ATPase activity are still poorly understood. Here, we show that
the two processes can bemeasured in a label-free and non-inva-
sive manner in real time in live cells, stably transfected with
CFTR. This study reveals three key findings. (i) The major con-
tribution (>90%) to the total CFTR-related ATP hydrolysis rate
is due to phosphorylation by PKA and the minor contribution
(<10%) to CFTR-ATPase activity. (ii) The mutant CFTR-
E1371S that is still conductive, but defective in ATP hydrolysis,
is not phosphorylated, suggesting that phosphorylation re-
quires a functional nucleotide binding domain and occurs in the
post-hydrolysis transition state. (iii) CFTR-ATPase activity is
inversely related to CFTR anion flux. The present data are con-
sistent with a model in which CFTR is in a closed conformation
with two ATPs bound. The open conformation is induced by
ATP hydrolysis and corresponds to the post-hydrolysis transi-
tion state that is stabilized by phosphorylation and binding of
chloride channel potentiators.
The cystic fibrosis transmembrane conductance regulator
(CFTR,3 ABCC7), with a molecular mass of 140 kDa, is a
channel for small anions such as chloride (or iodide) and bicar-
bonate (1). It belongs to the C-family of ATP-binding cassette
(ABC) transporters (ABCC) and is composed of two homo-
logous halves, each comprising a transmembrane (TMD) and a
nucleotide binding domain (NBD). As other members of the
ABCC family, CFTR lacks the catalytic glutamine in NBD1 and
carries it only in NBD2 (Glu-1371) (2). In NBD1, glutamine is
replaced by serine (Ser-573), which binds nucleotides tightly,
but significantly reduces the rate ofATPhydrolysis (3). The two
halves of the protein are linked by an intrinsically disordered (4)
regulatory (R) domain, unique to CFTR. This leads to the over-
all domain organization TMD1-NBD1-R-TMD2-NBD2 (5).
The R-domain is highly charged and contains numerous serine
residues that can be phosphorylated by protein kinases, partic-
ularly by the cAMP-dependent protein kinase A (PKA) (6). A
low resolution structure of CFTR, obtained by electron crystal-
lography in the absence of nucleotides and phosphorylation (7),
revealed strong similarity to the nucleotide-bound structure of
the homodimeric bacterial ABC transporter Sav1866 (8).
The function of the CFTR anion channel has been investi-
gated in great detail by different electrophysiological methods,
including iodide efflux measurements with iodide-sensitive
electrodes, Ussing chamber measurements, and most impor-
tantly patch clamp techniques (9). Although CFTR gating has
long been known to depend on the hydrolysis of nucleoside
triphosphate (generally ATP) (10, 11) and on phosphorylation
of the R-domain (12), information on direct measurements of
the two processes is sparse.
CFTR ATPase activity could so far be measured only with
radioactively labeled nucleotides in inside-out membrane vesi-
cles, as first demonstrated by Riordan and co-workers (13). The
maximum rate of ATP hydrolysis by phosphorylated CFTRwas
determined as Vmax  53.8 nmol mg1 min1 (14), in good
agreement with the catalytic rate constant or turnover number
determined as kcat 0.14 s1 (15). However, CFTR shows sig-
nificant (80–90%) functional attrition during reconstitution,
and therefore the turnover number was later re-estimated as
kcat  1–2 s1 (16), which brings it into the time frame for
channel gating (17). Further insight into the role of ATP hydro-
lysis was gained indirectly by investigating channel gating by
means of electrophysiological methods in the presence of dif-
ferent nucleotides (3, 18).
CFTR phosphorylation by PKA was first measured with
radioactively labeled ATP and subsequent immunoprecipita-
tion of phosphorylated CFTR in inside-out vesicles (13, 19) and
cells (6). Because separation of the two ATP-consuming pro-
cesses, CFTR-ATPase activity and PKA activity, is difficult, the
quantitative information of these approaches is limited. PKA-
dependent CFTR activation was therefore analyzed mainly
indirectly, again using electrophysiological methods (20, 21).
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Mutation of serine residues (Ser-660, Ser-737, Ser-795, and
Ser-813) revealed that none of the sites alone was essential.
Simultaneous mutation of all four serine residues substantially
reduced the PKA-stimulated current (22); yet mutation of as
much as 10 serine residues did not fully eliminate the PKA-
stimulated current (23). Notably, CFTR constructs lacking the
R-domain were still conductive and even exhibited a somewhat
higher affinity to nucleotides but shorter open times (24). The
unphosphorylated R-domain was therefore assumed to inhibit
CFTR channel opening by interfering with nucleotide binding
and dimerization, rather than by stabilizing NBD dimer forma-
tion, as proposed earlier (25, 26).
Presently, the most accepted model for CFTR function
assumes channel opening upon ATP binding at the interface
between the two NBDs, with concomitant formation of an out-
ward facing form (5, 27), and channel closing upon ATP hydro-
lysis at NBD2, with subsequent formation of an inward facing
form (28, 29). The model corresponds to the alternating access
mechanism (30), which has also been adapted to other ABC
transporters (31). This model is supported by the outward fac-
ing structures of Sav1866 with two identical nucleotides bound
(8, 32) and the inward facing (outward closed) structure of
the nucleotide-free P-glycoprotein (33). Alternating access to
CFTRwas confirmed recently by testing the accessibility of cys-
teines in the transmembrane domain with cysteine-reactive
probes. However, surprisingly, the “open state” of CFTR was
facing inward, and the “closed state” of CFTR was facing out-
ward (34). This finding raises new questions as to the role of the
ATP hydrolysis cycle for CFTR anion channel function.
To circumvent problems with the susceptibility of CFTR to
reconstitution, we measured the CFTR-related ATP hydrolysis
rate in live Chinese hamster ovary (CHO) and baby hamster
kidney (BHK) cells, stably transfected with human CFTR
(CHO-CFTR and BHK-CFTR cells). As ATP is re-synthesized
directly on demand, ATP hydrolysis can be monitored by mea-
suring the extracellular acidification rate (ECAR), if cells work
under glycolytic conditions (35–38), or the oxygen consump-
tion rate (OCR), if cells work under conditions of oxidative
phosphorylation (respiration) (39). In parallel, we measured
iodide efflux under comparable experimental conditions. As
phosphorylation agents, we used CPT-cAMP and forskolin.
CPT-cAMP causes dissociation of the regulatory and catalytic
subunits of PKA, which leads to R-domain phosphorylation by
the catalytic subunit, whereas forskolin acts indirectly by stim-
ulating cAMP synthesis through adenylate cyclase. In the pres-
ence of CPT-cAMP, the energy required to drive CFTR activity
(total CFTR-related ATPase activity) can thus be subdivided
into the energy consumed to drive PKA and CFTR-ATPase
activity, respectively. In the presence of forskolin, adenylate
cyclase activity may also contribute.
The following questions were asked. (i) How much ATP is
consumed by the individual processes contributing to the total
CFTR-related ATP consumption rate, PKA, CFTR-ATPase,
and adenylate cyclase activity, respectively? (ii) At which step of
the CFTR-ATPase activity cycle does phosphorylation of the
R-domain occur? (iii) How are phosphorylation of the R-do-
main by PKA and CFTR-ATPase activity related to anion
efflux? The answers to these questions allowed unraveling the
complex interplay between CFTR phosphorylation, CFTR-
ATPase activity, and anion flux. A new model for the CFTR-
ATPase activity cycle is proposed.
Experimental Procedures
Compounds—Capsaicin, CFTRinh-172, genistein, glibenclamide,
glipizide, 8-(4-Chlorophenylthio)-AMP (CPT-cAMP), forsko-
lin, methotrexate, and H-89 were obtained from Sigma. Myris-
toylated PKI(14–22), minimum essential medium (MEM),
DMEM, Dulbecco’s PBS, fetal bovine serum (FBS), and other
chemicals needed for cell culture were purchased from
LuBioScience (Luzerne, Switzerland). CPT-cAMP, PKI(14–22), and
H-89 stock solutionswere prepared inwater and forskolin solu-
tion in DMSO. The DMSO concentrations in cells always
remained low, CDMSO 0.5% (v/v), and had no influence on
cellular metabolism in agreement with previousmeasurements
(38). Methotrexate for cell culture was prepared as 100 mg/ml
stock in sterile 1 N NaOH.
Cell Lines—CHO and BHK cell lines stably transfected with
the human CFTR (CHO-CFTR, BHK-CFTR) or CFTR-E1371S
(BHK-E1371S) gene were the generous gifts fromDr. J. R. Rior-
dan (University of North Carolina) and Dr. Ju¨rgen Reinhardt
(Novartis, Switzerland).
Growth and Flow Media—For cell growth, MEM without
ribonucleosides and deoxyribonucleosides, containing 10%
heat-inactivated FBS, was used.
For flow medium preparation, commercially available dry
powder MEM (for CHO cells) or DMEM (for BHK cells) was
used. Both flow media were without FBS and without sodium
bicarbonate to maintain a very low buffer capacity. Sodium
chloride was used as a substitute to preserve osmotic balance.
The pH was adjusted to 7.4 at 37 °C.
Cell Culture—Non-transfected CHO cells were grown in
MEM at 37 °C and 5% CO2. Stably transfected cell lines were
cultured in the same medium supplemented with 50 Mmeth-
otrexate. Cells were split 1:15 and passaged every 2–3 days.
BHK cell lines expressing CFTR variants were grown in
DMEM/F-12, 1:1, supplemented with 10% FBS and 500 M
methotrexate under the same conditions as CHO cells.
ECAR and OCR Measured with a Bionas—The Bionas Dis-
covery 2500 cell-analyzing system (39) consists of six parallel
measuring chambers. Cells were directly seeded on Bionas
SC1000 metabolic chips with oxygen, pH, and impedance sen-
sors to reach a final number of n 3105 cells per chip, which all
contributed to the ECAR. The pH sensors measure the voltage
change as a function of time that is linearly related to a pH
change as a function of time. Oxygen sensors measure the cur-
rent change as a function of time that is linearly related to oxy-
gen concentration in solution as a function of time (for calibra-
tion, see below).
Cells were incubated for 4 h with growth medium. To start a
stimulation cycle, cells were switched to flow medium with
a flow rate, r 110 l/min in each measuring chamber, until a
stablebasalmetabolic ratewas reached (about2h).Cellswere then
exposed to medium containing phosphorylation agents, until a
steady state was reached. After each stimulation cycle, cells were
flushedagainwithpuremediumuntilbasal activitywas reached, to
ensure that stimulationswere fully reversible. Arrival of the titrant
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in the measurement chamber was monitored from changes in
impedance values and was moreover calculated taking into
account the dimensions of the tubing system. Pump cycles con-
sisted of a 2-min go and a 2-min stop, yielding a time resolution of
4 min. Acidification was measured in the stop phase.
ECAR Measured with the Cytosensor—The Cytosensor
microphysiometer (Molecular Devices) (35, 40) consists of
eight light-addressable potentiometric sensors. It offers a sec-
ond tubing system that was filled with flowmedium containing
the titrant (e.g. CPT-cAMP or forskolin) and allows applying
agents with little delay, as a valve close to the measurement
chamber can be switched between the two channels. Because of
the shorter tubing system, compound adsorption to the walls of
the tubes is comparatively low.
Cells were grown as a layer on 3.0-m polycarbonate mem-
branes (inner diameter, 12 mm, Corning) on the bottom of a
flow chamber in diffusive contact with the sensors. The sensors
again measure the voltage change as a function of time. Cells
were seeded to reach a final number of NC  5105 cells per
membrane, corresponding to 80–90% confluency; however,
because of the flow cell geometry, only 33% of the cells con-
tribute to the ECAR signal detected by the sensors (NC 
1.65105 cells). Cells were incubated either for 4 h or overnight
with growthmedium,whichwas then switched to flowmedium
with a flow rate, r  100 l/min. Extracellular acidification
rates were calculated using Molecular Devices Cytosoft, and
the slope between 5 s after stopping and 2 s before restarting the
pump was evaluated to avoid artifacts caused by pump switch-
ing (for pump cycle see Fig. 1 in Ref. 41). The Cytosensor
showed a time resolution of 2 min. To quantify the observed
ECAR changes, four measurement points at the end of each
drug exposure period were averaged and normalized to the
average of the last four points of the basal ECAR before sub-
stance application, taken as 100%.
Quantification of Acid Export—The measured voltage
change per time ECARV (V s1) was transformed to the effec-
tive ECAR (protons released cell1 s1) based on a calibration
(cal) showing that 61.0 1.1 mV corresponded to 1 pH unit in
the Cytosensor (37) and 48.0  2.5 mV to 1 pH unit in the
Bionas as shown in Equation 1,
ECAR ECARV    V  NA/(cal  NC) (Eq. 1)
The buffer capacity of the flowmediumwas determined as 
0.596 mM, taking into account phosphate salts (0.91 mM) and
the amino acids glutamine (2 mM), histidine (0.2 mM), and cys-
teine (0.57 mM) (42). The volumina of the flow chambers were
V 2.8 l for the Cytosensor, and V 5.65 l for the Bionas.
NA is the Avogadro number, and NC is the number of cells
contributing to the ECAR (NC  1.65105 in Cytosensor and
NC 3105 in Bionas).
Lactate Quantification—Experiments in the Cytosensor
were carried out as described above, but the flow medium was
replaced by phosphate buffer (0.3mMCaCl2, 0.6mMMgCl2, 0.5
mM KH2PO4, 3 mM KCl, 0.5 mM Na2HPO4, 130 mM NaCl, 10
mM glucose). The buffer was collected after leaving the mea-
surement chamber. All cells contributed to lactate efflux. The
sampleswere lyophilized and dissolved again in 3ml of buffer (1
M glycine, 0.6 M hydrazine, 5.6 mM EDTA) at pH 9.5. Lactate
dehydrogenase (5000 units/ml) and NAD (2.5 mM) were added
to the buffer, and the absorbance increase at 340 nm was mon-
itored. Lactate concentrations were calculated from the stable
absorption at 340 nm reached at the end of the reaction (37).
Quantification of Oxygen Consumption—Assuming that the
measured current I(k) changes linearlywith the oxygen concen-
tration in solution, the oxygen consumption per time 	n/	t
(mol s1) was determined as shown in Equation 2,
	n
	t
 Vr, chip  CO2,S 	I
k	t  Ibas
k (Eq. 2)
where I(k) corresponds to1 nA andwas set to 100% in each go
phase to correct for the potential drift; CO2, S is the concentra-
tion of oxygen in aqueous solution at 37 °C (CO2, S 0.214mM);
	I(k) is the measured change in current (e.g. 	I(k)  1.5 pA)
reflecting the change in oxygen consumption, and Vr, chip is the
volume of the flow chamber (Vr, chip 5.65 l).
ATPHydrolysis Rates—ATP hydrolysis rates were calculated
taking into account that glycolysis yields twomolecules of lactic
acid per molecule of glucose consumed and produces twomol-
ecules of ATP. Respiration yields 36 molecules of ATP per
molecule of glucose,whereas sixmolecules of dioxygen are con-
sumed (35). One molecule of dioxygen consumed thus corre-
sponds to six molecules of ATP produced (42).
Iodide Efflux Measurements—Iodide efflux measurements
were carried out according to Chen et al. (43) with small mod-
ifications. CHO cells were grown to 90% confluence in 60-mm
culture dishes and were washed three times with 2.5ml of load-
ing buffer, pH7.4, inwhich chloridewas replaced by iodide (136
mM NaI, 3 mM KNO3, 2 mM Ca(NO3)2, 11 mM glucose, 20 mM
HEPES/NaOH). After incubation for 3 h in the dark at 37 °C,
cells were washed carefully 30 times with 2.5ml of efflux buffer,
pH 7.4, in which chloride was replaced by nitrate (136 mM
NaNO3, 3 mM KNO3, 2 mM Ca(NO3)2, 11 mM glucose, 20 mM
HEPES/NaOH) to remove excess iodide. For iodide effluxmea-
surements, efflux buffer was exchanged in 1-min intervals.
After 5 min, efflux buffer was replaced by stimulation buffer
(i.e. efflux buffer containing CPT-cAMP or forskolin). Samples
were collected and stored in the dark at room temperature. An
iodide-selective electrode (Mettler Toledo, perfectIon combi-
nation I) was used to measure voltages of the samples. Iodide
concentrations were calculated using a calibration curve
obtained with efflux buffer containing various concentrations
of NaI. All experiments were carried out at 37 °C.
Models—PKA activation by CPT-cAMP was fitted with
Equation 3 as proposed previously for PKA in solution (44),
ECAR 100 
ECARmax 100 C
CPTKd, app C
CPT
4
(Eq. 3)
The term in brackets reflects the activation of PKA by binding
four cAMPmolecules to the regulatory subunit and subsequent
dissociation of regulatory and catalytic subunits.
The CFTR-ATPase activity versus modulator concentra-
tion curves were fitted with Equation 4, which is based on a
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two-site binding model previously proposed for P-glycopro-
tein (38, 45).
V 
K1K2V0  K2V1C  V2C
2
K1K2  K2C  C
2 (Eq. 4)
Here V is the velocity reflecting the change in ATPase activity
or ECAR; K1 is the concentration of half-maximum activation;
K2 is the concentration of half-maximum inhibition; V0 is the
normalized basal activity; V1 is the maximum activity; V2 is the
minimumactivity, andC the allocrite concentration in aqueous
solution. Experiments were performed under steady state
conditions.
Results
Glycolysis and Oxidative Phosphorylation—Cultured cells
generally work under glycolytic conditions in the presence of
glucose as a carbon source (35). However, they possess the abil-
ity to shift dynamically between glycolysis and oxidative phos-
phorylation (or respiration) (46). To test which of the twomet-
abolic pathways predominates under the present conditions,
we measured the ECAR and the OCR of CHO-K1 and CHO-
CFTR cells in flowmedium without and with the phosphoryla-
tion agents CPT-cAMP and forskolin. Seven stimulation cycles
were measured in sequence with increasing concentrations of
CPT-cAMP (Fig. 1, A and B) and forskolin (Fig. 1, C and D),
using a Bionas Discovery 2500. CPT-cAMP barely influenced
the ECAR of CHO-K1 control cells (Fig. 1A). Conversely, it
strongly stimulated the ECAR of CFTR-transfected cells (Fig.
1B). ECAR maxima were reached at incubation times, t 20
min. The OCR increased only at the highest CPT-cAMP con-
centrations (CCPT 100 M) and was delayed by about 24 min
relative to the ECAR.
The effect of forskolin was again small in CHO-K1 cells (Fig.
1C) and significantly more pronounced in CHO-CFTR cells
(Fig. 1D). At higher forskolin concentrations (5th stimulation),
the ECAR started to decrease and the OCR to increase in
CHO-K1 and CHO-CFTR cells, indicating a decrease in glycol-
ysis and an increase in respiration in both cell types. At even
higher concentrations (6th stimulation), respiration became
predominant. Washout (i.e. flushing cells with pure medium)
after stimulationwith high forskolin concentrations led to dilu-
tion of the compound and, as a consequence, to an ECAR re-
bounce. Whereas basal OCR was reached relatively rapidly
(within a fewminutes), the basal ECARwas reached only slowly
(within more than an hour). Analogous washout effects,
although with smaller amplitudes, were observed in CHO-K1
cells (see 6th stimulation).
In conclusion, CHO-K1 and CHO-CFTR cells worked under
glycolytic conditions (yielding two molecules of ATP per mol-
ecule of glucose) in pure medium, as well as in the presence of
CPT-cAMP up to the highest concentrations at incubation
times, t 24 min. In the presence of low forskolin concentra-
tions (Cfsk 0.1–1M), the situationwas identical. However, at
higher concentrations, forskolin reduced cellular glucose
uptake (47–49) and as a consequence cells shifted from glycol-
ysis to themore efficient respiration (yielding36molecules of
ATP/molecule of glucose) (Table 1, end).
ECAR in CHO-K1 and CHO-CFTR Cells Measured as a
Function of CPT-cAMP and Forskolin Concentration—For
quantitative data evaluation, we repeated titrations of CHO-K1
and CHO-CFTR cells with CPT-cAMP and forskolin using a
Cytosensor (that measures only the ECAR), because it shows
less adsorption of hydrophobic compounds to the tubing sys-
tem and has a higher time resolution. The ECAR of CHO-K1
and CHO-CFTR cells is shown as a function of the CPT-cAMP
(Fig. 2A) and forskolin (Fig. 3A) concentration, respectively. As
in Fig. 1A, CHO-K1 cells showed only a low response with a
maximum of 142  9% at high CPT-cAMP concentrations
(CCPT 200 M), whereas CHO-CFTR cells again showed a
significant ECAR increase with a maximum ECAR of 195 
20% at CCPT 400 M.
In the case of forskolin, the ECAR of CHO-K1 cells remained
at the basal level at low concentrations, increased only slightly
(maximum125 18%) at higher concentrations up toCfsk 10
M, and then decreased belowbasal values, reaching only50%
of initial basal value atCfsk 100M.TheECARofCHO-CFTR
cells increased already at low concentrations (Cfsk1 M) and
reached a maximum of 195 20% at the concentration Cfsk
1 M. At higher concentrations, the ECAR started to decrease
as for CHO-K1 cells and reached only 30% of the initial basal
value at the concentration Cfsk  100 M. As seen in Fig. 1, C
and D, the decrease in ECAR is compensated by an increase in
OCR and can be attributed to a shift from glycolysis to respira-
tion in CHO-K1 and CHO-CFTR cells.
ECAR Corresponds to Lactate Efflux and Reflects the Rate of
ATP Hydrolysis—To test whether the ECAR induced upon
stimulation with CPT-cAMP corresponds to lactate export, we
superfused CHO-CFTR cells with 50 M CPT-cAMP for 2 h
and collected the medium after it had passed the measurement
chambers. Lactate was then quantified as described under
“Experimental Procedures” (37). Basal acidification rates were
determined as vL 4106 lactic acid molecules extruded cell1
s1, which corresponds to vATP 4106 ATP molecules cell1
s1 hydrolyzed via glycolysis. Upon stimulation with CPT-
cAMP (CCPT  50 M), lactate efflux increased to 180  10%
relative to basal values (100%) corresponding to vL  7.2106
lactic acid molecules extruded cell1 s1. The values obtained
by lactate determination are in close agreement with the values
obtained by ECARmeasurements (see below) and confirm that
cells worked under glycolytic conditions.
ATP Hydrolysis Rate Derived from ECAR and OCR—The
basal ECAR of CHO-K1 and CHO-CFTR cells, respectively,
was determined as vbas, H 4.22106 0.44 protons cell1 s1
(0.42 amol cell1 min1) if measured with the Bionas and as
vbas, H 4.94106 0.46 protons cell1 s1 (vbas, H 0.49 fmol
cell1 min1) if measured with the Cytosensor for both cell
lines (see Equation 1). As shown above, the protons measured
corresponded to lactic acid molecules extruded.
The basal oxygen consumption rates of CHO-CFTR and
CHO-K1 were determined as vbas, ox 0.63 fmol cell1 min1
for both cell lines (see Equation 2). This value is within the
range of published basal oxygen consumption rates (voxygen 
0.1–10 fmol cell1 min1) (50). The basal ECAR and OCR val-
ues (100%) were used for further quantification.
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The ATP hydrolysis rate as a function of the CPT-cAMP
concentration as derived from ECAR values (Fig. 2A) is shown
in Fig. 2B. The ATP hydrolysis rate at t 40minwas calculated
by taking into account the OCRmeasured with the Bionas (last
stimulation points in Fig. 1B). After correction for OCR, the
ATP hydrolysis rates measured at the two different time points
(t 20 and 40 min) were identical, suggesting that phosphory-
lation reached a steady state at 20 min.
The ATP hydrolysis rate as a function of forskolin concen-
tration (Fig. 3B) was estimated, combining ECAR (Fig. 3A) and
FIGURE 1. A–D, ECAR and OCR of CHO-K1 and CHO-CFTR cells upon titration with CPT-cAMP and forskolin measured with a Bionas Discovery 2500.
ECAR (f) andOCR (‚) of CHO-K1 (A) andCHO-CFTRcells (B) at increasingconcentrationsofCPT-cAMP (CCPT1, 5, 10, 50, 100, 200, and320M) are shown. ECAR
(f) and OCR (‚) of CHO-K1 (C) and CHO-CFTR cells (D) at increasing concentrations of forskolin (Cfsk, applied  0.1, 1, 2, 5, 10, 50, and 100 M) are shown.
Measurements were performed at 37 °C. Rates were measured for 2 min, followed by 2 min of flushing with flow medium; a measurement point was thus
generated every 4 min. Horizontal lines indicate the presence of phosphorylation agents in flowmedium. Cells were stimulated with phosphorylation agents
during 24 min at low concentrations and 32 min at higher concentrations. The concentrations given correspond to the concentrations applied; as the
hydrophobic forskolin adsorbed to the tubing system, the concentrations reaching the measuring chambers were somewhat lower. Washout with pure flow
medium after application of high forskolin concentrations induced an ECAR re-bounce due to forskolin dilution.
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OCR measurements (Fig. 1D). Data in the intermediate con-
centration range could not be determined accurately and were
omitted.
Apparent CFTR-related Catalytic Rate Constant—Upon
stimulation of CHO-CFTR cells with CPT-cAMP (CCPT  50
M), the total CFTR-related basal ATPhydrolysis rate (vbas, H
TABLE 1
Present and previous parameters related to PKA, CFTR-ATPase, and CFTR channel activity
Agent Function Parameter Ref.
CPT PKA activity cAMP dissociation constant in CHO-CFTR cells, Kd ,app8.5 M Present
CPT PKA activity cAMP dissociation constant in BHK-CFTR cells, Kd ,app3.7 M Present
CPT PKA activity cAMP dissociation constant in aqueous solution, Kd ,app2.9 M 56
CPT PKA activity Apparent half-max. phosphorylation (t 20 min), K0.540 M Present
CPT PKA activity Apparent half-max. phosphorylation (t 8 min), K0.540 M Present
CPT PKA activity Apparent half-max. phosphorylation (t 6 min), K0.563 M Present
CPT PKA activity Apparent half-max. phosphorylation (t 4 min), K0.583 M Present
CPT PKA activity Apparent half-maximal channel activation, K0.580 M 9
CPT CFTR-ATPase Partially phosphorylated: approximate catalytic rate constant, kcat 14 s1 Present
CPT CFTR-ATPase Fully phosphorylated: app. catalytic rate constant, kcat 1 - 2 s1 16
CPT CFTR I efflux ATP-independent increase at CCPT400 M Present
Fsk CFTR I efflux ATP-independent increase at Cfsk15 M Present
Fsk Metabolism Cells shift from glycolysis to respiration at Cfsk10 Ma Present
Fsk Metabolism Metabolic effects Cfsk20 M 9
a Effect starts gradually and becomes dominant at Cfsk10 M.
FIGURE 2.A and B. ECAR of CHO-K1 and CHO-CFTR cells as a function of
CPT-cAMP concentration. ECAR of CHO-K1 () and CHO-CFTR (f) cells
measured with a Molecular Dynamics Cytosensor at 37 °C for 30 s every 2
min is shown. A, either the average of the last four points of the measure-
ments during perfusion with CPT-cAMP for20 min (ECAR maximum) (f)
or 40min (*) was normalized to the basal value before stimulation andwas
plotted against CPT-cAMP concentration. Extended superfusion (40 min)
at high forskolin concentrations was used to monitor a potential ECAR
decrease, reflecting the transition from glycolysis to respiration (see Fig.
1). Error bars represent the standard deviation of 3–6 measurements. For
clarity, errors bars are shown only for ECAR maxima but are in the
same order of magnitude for ECAR after 40 min. The solid line represents
the best fit of Equation 3 to the ECAR data with a dissociation constant for
CPT-cAMP, Kd, app 8.5 M and an ECARmax 209%. CHO-K1 cells start to
respond only at concentrations higher than 50M resulting in amaximum
ECAR of 130% at 400M CPT-cAMP. B, ECARwas transformed to the rate of
ATP synthesis/hydrolysis taking into account the OCR data of
Fig. 1B.
FIGURE 3. A and B. ECAR of CHO-K1 and CHO-CFTR cells as a function of
forskolin concentration. ECAR of CHO-K1 () and CHO-CFTR (f) cells mea-
sured in aMolecular Dynamics Cytosensor at 37 °C for 30 s every 2min. A, last
four points of measurements (8 min) during perfusion with forskolin were
averaged, normalized to the basal value before stimulation, and plotted
against forskolin concentration.Error bars represent the standarddeviationof
2–4 experiments. ECAR response of CHO-CFTR cells showed an increase at
lower andadecrease at higher concentrationswith amaximumof 19519%
of basal ECAR at 1 M forskolin. CHO-K1 cells only responded at concentra-
tionsCfsk10Mwith aminimal ECARof 35%atCfsk100M. Thedotted line
shows thebasal ECAR toguide theeye.B, rate ofATP synthesis/hydrolysiswas
roughly estimated taking into account the OCR data of Fig. 1D.
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0.49 fmol cell1 min1) (Fig. 2, A and B) increased by 	vmax
0.48 fmol cell1 min1 (corresponding to 4.82106 ATP cell1
s1). The number of electrophysiologically active CFTR chan-
nels per CHO-CFTR cell was estimated previously by dividing
the whole cell current by the single channel amplitude as E0
(3.4447  0.4171)104.4 The corresponding CFTR-related
apparent ATP turnover number or apparent catalytic rate con-
stant was estimated as shown in Equation 5,
kcat, app
	vmax
E0
 140s1 (Eq. 5)
Notably, the apparent catalytic rate constant obtained in the
presence of CPT-cAMP consists of the phospho group trans-
ferase activity of PKA and the ATPase activity of CFTR.
PKA Activity Is the Major Contribution and CFTR-ATPase
Activity Is the Minor Contribution—To assess the relative con-
tribution of the PKA activity to the total CFTR-related ATP
hydrolysis rate, we inhibited the latter with two well known
protein kinase inhibitors, themyristoylated PKA inhibitor pep-
tide PKI(14–22) (Ki 36 nM) and the PKA inhibitorH-89 (Ki
135 nM). Both were applied at a concentration (Ci  20 M)
previously proven to completely inhibit PKA activity in live
cells (51–53). Cells were incubated with the inhibitors for
30–40 min before stimulation with CPT-cAMP or forskolin.
Both inhibitors influenced the ECAR and thus the cell metab-
olism. PKI(14–22) transiently enhanced the ECAR to about
190%, most likely due to its detergent-like nature; however, the
signal returned to basal values during the incubation period.
H-89 enhanced the ECAR of all cell lines to about 180% and
stabilized at a high level (data not shown). In the case of H-89,
observations were therefore normalized to this altered basal
activity. Both inhibitors reduced the stimulation with either
CPT-cAMPor forskolin to low values of110% as summarized
inTable 2. ThemajorATPhydrolysis rate (90%) could thus be
attributed to phospho group transferase activity of PKA. The
strong down-regulation of the ECAR at high forskolin concen-
trations (Cfsk 10 M) was not influenced by the PKA
inhibitors.
Although we could not fully exclude a low prevailing PKA
activity, we assumed that the minor (	10%) remaining contri-
bution to the total CFTR-related ATP hydrolysis rate was due
to ATP hydrolysis of partially phosphorylated CFTR. The cat-
alytic rate constant of CFTR-ATPasewas estimated as kcat, CFTR
	14 s1. This is in the order of the catalytic rate constant of
P-glycoprotein (36, 54, 55) and is also in broad agreement with
a previous estimate of the catalytic rate constant of fully phos-
phorylated CFTR, kcat, CFTR 1–2 s1 (16).
CFTR Phosphorylation by PKA—Because PKA activity was
responsible for almost the total ECAR orATP hydrolysis rate in
the presence of CPT-cAMP, the ECAR versusCPT-cAMP con-
centration curves obtained with CHO-CFTR and BHK-CFTR
cells (Figs. 2,A andB, and 4A) could bewell fittedwith Equation
3 (44) describing cAMP dissociation from PKA (i.e. PKA acti-
vation). The resulting apparent dissociation constants, Kd, app,
of CPT-cAMP fromPKA in both cell lines (for data see Table 1)
were in good agreementwith previous data, obtainedwith puri-
fied PKA in aqueous solution (56). The good agreement
between the behavior of purified and cellular PKA further sup-
ports the assumption that the major contribution to CFTR-
related ATP hydrolysis was due to PKA activity.
The concentration of half-maximum channel activation by
CPT-cAMP was determined as K0.540 M at 20 and 40 min.
With decreasing incubation times, the parameter, K0.5,
increased and reached a value ofK0.583Mat 4min (Table 1),
which is in good agreement with a value obtained by patch
clamp measurements (9).4 Dr. J. Reinhardt (Novartis, Switzerland), personal communication.
TABLE 2
Inhibition of CFTR Phosphorylation by PKA
Cells were incubated with the PKA inhibitors H-89 and myristoylated PKI(14–22)
fragment for 40 or 30min before stimulationwithCPT-cAMP (100M) or forskolin
(1 M), and forskolin (50 M).
Inhibitor
CPT-cAMP
(100 M)
Forskolin
(1 M)
Forskolin
(50 M)
% % %
No inhibitor 180 195 64
PKI (10 M) 145 143 NDa
PKI (20 M) 115 NDa NDa
H89 (20 M) 110 111 68
aND, not determined.
FIGURE 4. A and B. ECAR of BHK cells overexpressing CFTR variants as a
function of CPT-cAMPand forskolin concentration. ECAR of BHK-CFTR (f)
and BHK-E1371S (E) cells measured in a Molecular Dynamics Cytosensor at
37 °C is shown. Error bars represent the standard deviation of 2–4 experi-
ments.A, for BHK-CFTR cells stimulationwithCPT-cAMP resulted in amaximal
ECAR of 123 7% at CCPT 100 M; in BHK-E1371S cells the ECAR is slightly
reduced toaminimumof844%atCCPT50M relative tobasal values. The
solid line represents a fit of Equation 3 to data with a dissociation constant for
CPT-cAMP, Kd, app  3.7 M and an ECARmax  125%. B, upon titration with
forskolin, a maximal ECAR of 117  4% is stably reached for concentrations
0.5  Cfsk 	 10 M in BHK-CFTR cells. BHK-E1371S cells show a reduction
down to 91 3% in this concentration range. At concentrations Cfsk10M,
a decrease in ECAR of both cell lines was observed.
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CFTR Phosphorylation Occurs in the Post-hydrolysis Transi-
tion State—To test whether CFTR-ATPase activity was
required for phosphorylation, we used the ATPase-deficient
CFTR mutant CFTR-E1371S. It was demonstrated to express
well in CHO cells (1), and to exhibit prolonged open times (17).
The present experimentswere performedwith BHKcells under
the conditions described above for CHO cells, except that
DMEM(without bicarbonate)was used as flowmedium instead
of MEM to preserve the conditions used for cell culture. The
response of BHK-CFTR cells to stimulation with CPT-cAMP
was qualitatively similar to that of CHO-CFTR cells; however,
the maximum ECAR was lower (123 7% at CCPT 100 M)
(Fig. 4A). The response to forskolin (Fig. 4B) was also similar to
that in CHO cells, but the ECARwas again lower and reached a
maximum stimulation of 117  4% around Cfsk  1 M. At
higher forskolin concentrations, the ECAR started to decrease
as shown above in CHO cells (Fig. 3A).
Importantly, BHK-E1371S cells showed no ECAR increase
upon addition of phosphorylation agents (Fig. 4). Hence, BHK-
E1371S with the hydrolysis-deficient NBD2 was not only
unable to hydrolyze ATP, as expected, but moreover could not
be phosphorylated.As phosphorylation of BHK-E1371S did not
occur, we concluded that ATPase activity is required for phos-
phorylation and that phosphorylation most likely occurs in the
post-hydrolysis transition state. The slight but distinct ECAR
decrease (or alkalinization) to 84 4% at CCPT 50 M in Fig.
4A was most likely due to direct efflux of bicarbonate ions by
CFTR-E1371S and possibly also by chloride/bicarbonate
exchange proteins regulated indirectly (57, 58).
CFTR-ATPase Activity Is Enhanced by Anion Channel
Inhibitors—Next, we investigated how the CFTR-ATPase
reacts to chloride channel inhibitors, known to specifically
interact with CFTR, including glibenclamide (Fig. 5) glipizide
(Fig. 6), and CFTRinh-172 (Fig. 7). For this purpose, we phos-
phorylated CHO-K1 control cells and CHO-CFTR cells with
different CPT-cAMP concentrations (CCPT  5–100 M) as
described above, whereby phosphorylation was kept constant
throughout the subsequent titration experiment. Cells were
incubated for 20 min with the particular drugs at each concen-
tration. The interval length and conditions were chosen to
ensure that a stable ECARwas reached and the cell metabolism
remained glycolytic. After each stimulation period, cells were
flushed with medium containing only CPT-cAMP until the
ECAR returned to basal values, showing that ECAR changes
were reversible at all conditions.
In CHO-K1 cells, anion channel inhibitors induced only neg-
ligibly small effects (120%) except CFTRinh-172, which
reached ECAR values of 138% at CCPT  50 M. In CHO-
CFTR cells, all there anion channel inhibitors induced bell-
shapedCFTR-ATPase activity curves with ECARmaxima up to
210% (Figs. 5–7). Titration curves could be well fitted with
Equation 4 that assumes ATPase activation at low and inhibi-
tion at high allocrite concentrations as shown previously for
P-glycoprotein in inside-out lipid vesicles (36, 45, 59) and in
cells (36, 38). Kinetic analysis (Equation 4) of the titration
curves in the presence of different concentrations of CPT-
cAMP (Figs. 5–7) yielded the concentration of half-maximum
CFTR-ATPase activation,K1, and inhibition,K2, aswell asmax-
imum, V1, and minimum activity, V2, summarized in Table 3.
CFTR-ATPase Activity Is Reduced by Anion Channel
Potentiators—Analogous titrations of CHO-K1 and CHO-
CFTR cells, respectively, were performed with the potentiators
genistein (Fig. 8A) and capsaicin (Fig. 8B). In contrast to inhib-
itors, potentiators showed no ECAR increase. Higher concen-
FIGURE 5.A–H. Effect of glibenclamide on ECAR and iodide efflux in com-
parisonwith published data on channel function. A–C, ECAR as a function
of glibenclamide concentration in CHO-K1 () and CHO-CFTR (f) cells after
stimulation with CPT-cAMP concentrations CCPT 5M (A), CCPT 25M (B),
or CCPT 50 M (C). The solid lines are fits of Equation 4 to the data. D, con-
centration rangewhere no enhancement (cross-hatched bars) of iodide efflux
was observed after stimulation with CCPT 25 M. It has to be noted that an
unspecific increase of iodide efflux in control cells and transfected cells was
observed for concentrations Cglib 10 M. E, glibenclamide concentrations
causing no effect (cross-hatched) or inhibition (filled bars) of short-circuit cur-
rent stimulated by 100 M CPT-cAMP in CFTR-expressing FRT cells (89). F,
inhibitory concentrations of glibenclamide detected in analysis of single-
channel patch clamp experiments in stably transfected C127 cells in the pres-
ence of PKA (90). G and H, concentration range reported to cause channel
block by glibenclamide in excised patches from Xenopus oocytes in the pres-
ence of 50 units/ml PKA (91). Data obtained from biological triplicates are
shown with standard deviations.
CFTR Phosphorylation, CFTR-ATPase Activity, and Anion Flux
14490 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 28•JULY 8, 2016
 at U
niversitaetsbibliothek M
edizin on January 25, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
trations even reduced the ECAR of CHO-K1 and CHO-CFTR
cells down to a minimum of 55 and 35%, respectively, in the
case of genistein (Fig. 8A) and 65 and 50%, respectively, in the
case of capsaicin (Fig. 9A). The ECAR decrease at high poten-
tiator concentrations was fully reversible under all conditions
in both cell lines.
Anion Channel Potentiators Induce Cellular Respiration—At
concentrations relevant for anion channel activation, potentia-
tors such as genistein (Fig. 8) and capsaicin (Fig. 9) significantly
reducedECAR in bothCFTRoverexpressing (CHO-CFTR) and
control (CHO-K1) cells. As for forskolin (47–49), inhibition of
glucose import has been observed for several flavonoids,
including genistein, e.g. in U937 cells (60) and CHO cells (61).
To our knowledge, the influence of capsaicin on glucosemetab-
olism has not yet been described. Both potentiators thus
seemed to reduce glucose uptake, which leads to a reduction in
glycolysis and to an increase in respiration as observed for for-
skolin (Fig. 1D).
CPT-cAMP and Forskolin Not Only Act as Phosphorylation
Agents but also as CFTR Modulators—The CFTR-ATPase
activity curves were measured at different CPT-cAMP concen-
trations (Figs. 5–7). With increasing concentrations of CPT-
cAMP, the apparent concentration of half-maximum CFTR-
ATPase activation, K1, decreased. The shift to lower values
was particularly evident for the more hydrophilic glibencl-
amide and glipizide (Fig. 7 and Table 3), and it was less pro-
nounced for the more hydrophobic CFTRinh-172. The max-
imum ATPase activity, V1, of CFTR, induced by the chloride
channel inhibitors (i.e.ATPase activators) increased at very low
CPT-cAMPconcentrations and decreased at higher concentra-
tions (CCPT 25 M). Analogous shifts of kinetic constants of
CFTR with the CPT-cAMP concentration were observed pre-
viously for the potentiator genistein (62).
The phenomenon described above is typical for ABC trans-
porters such as P-glycoprotein, which are able to simultane-
ously accommodate different molecules in their binding
FIGURE 6. A and B. Effect of glipizide on ECAR and iodide efflux in com-
parison with published results on channel function. A and B, ECAR as a
function of glipizide concentration in CHO-K1 () and CHO-CFTR (f) cells
after stimulation with CCPT 25M (A) or CCPT 50M (B). The solid lines are
fits of Equation 4 to thedata.C, concentration rangewherenoenhancements
on iodide efflux after stimulation with CCPT 25 M were observed. D, con-
centration range reported to cause channel block by glipizide in excised
patches from Xenopus oocytes in the presence of PKA (91). Data obtained
from biological duplicates are shown with standard deviations.
FIGURE 7. A–C. Effects of CFTRinh-172 on ECAR and iodide efflux in com-
parison with published results on channel function. A–C, ECAR as a func-
tion of CFTRinh-172 concentration in CHO K1 () and CHO-CFTR (f) cells
after stimulationwith CCPT 5M (A), CCPT 25M (B), and CCPT 50M (C).
The solid lines are fits of Equation 4 to the data.D, concentration rangewhere
no enhancement of channel function was observed in iodide efflux experi-
ments after stimulation with CCPT 25 M. E, inhibition of channel function
described in literature for iodide influx after stimulationwith an CFTR activat-
ing mixture containing 5 M forskolin, 100 M Isobutylmethylxanthine, and
25 M apigenin (89). F, concentration range reported to cause inhibition of
CFTR-dependent short-circuit current after stimulation with 100 M CPT-
cAMP (89).G, concentration rangedescribed toblockCFTR in excisedpatches
from transfectedmouse embryo fibroblasts (92). Data obtained from biolog-
ical duplicates are shown with standard deviations.
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regions (63–65). The enhanced CFTR-ATPase activity in the
presence of very low concentrations of CPT-cAMP and the
reduced CFTR-ATPase activity in the presence of higher
concentrations of CPT-cAMP thus likely arise from a direct
combined modulatory interaction of CPT-cAMP and e.g.
glibenclamide or glipizide with CFTR. Evidence for binding
of cAMP to CFTR has been provided previously (66). More-
over, it is known that ABCC4, which is the ABC transporter
most closely related to CFTR, is a cAMP and cGMP exporter
(67, 68). CPT-cAMP as well as forskolin may thus not only
act as phosphorylation agents but also as modulators of the
CFTR-ATPase.
Iodide Efflux at Different Concentrations of Phosphorylation
Agents—To be able to directly compare ATPase activity and
anion channel activity of CFTR, we used the same cell lines
(CHO-CFTR andCHO-K1 cells) for both types of experiments.
Moreover, we tested whether cells responded equally in Cyto-
sensor experiments if MEM was replaced by iodide efflux
buffer (2mMHEPES versus 20mMHEPES). As the basal ECARs
were similar under the two conditions, we concluded that a
direct comparison of ATPhydrolysis and iodide effluxwaswar-
ranted. Fig. 10, A and B, shows the iodide flux at different con-
centrations of CPT-cAMP and forskolin, respectively, mea-
sured as a function of time. At low concentrations, maximum
iodide efflux was reached after a 3–4-min incubation time; at
high concentrations (Cfsk  50–100 M) maximum efflux
shifted to shorter incubation times of maximally 1 min (data
not included). Iodide efflux as a function of time is given in
Fig. 10.
ATP-dependent and ATP-independent Increase in Iodide
Efflux in the Presence of Phosphorylation Agents—Maximum
iodide efflux increased with the concentration of CPT-cAMP
(Fig. 11A) and reached a first plateau (VI 18.4 fmol cell1
min1) in the concentration rangeCCPT 300–400M. Anal-
ysis of the ECAR versusCPT-cAMP concentration curves (Figs.
2A and 4A) (see Equation 3) suggests that phosphorylation is
completed at CCPT400 M. A further concentration increase
to CCPT  600 M lead to a further distinct increase in iodide
TABLE 3
Kinetic constants of the CFTR-ATPase derived frommicrophysiometry experiments with CHO-CFTR cells in MEM at pH 7.4 and T 37 °C
The concentration of half-maximum activation (inhibition) K1 (K2) and the rate of activation (inhibition) V1 (V2) were obtained by fitting Equation 1 to the data.
Compound CCPT K1 K2 V1 V2 ECARmax
M M M % % %
Glibenclamide 5 25.0 105.1 315 0 192 19
Glibenclamide 10 9.9 67.3 332 0 214 32
Glibenclamide 25 3.0 68.8 275 0 210 27
Glibenclamide 50 1.0 85.3 192 0 165 16
Glibenclamide 100 1.5 63.4 207 0 166 16
Glipizide 25 56.4 80 231 100 148 10
Glipizide 50 6.25 80 198 100 161 16
CFTRinh-172 5 1.0 2.4 190 130 145
CFTRinh-172 25 0.5 3.8 250 150 189 27
CFTRinh-172 50 0.4 12.7 210 80 175 10
FIGURE 8. A–F. Effects of genistein on ECAR and iodide efflux in compar-
ison with published results on channel function. A, ECAR as a function of
genistein concentration in CHO K1 () and CHO-CFTR (f) cells after stimula-
tion with CCPT 50M. B, concentration range where potentiation (hatched)
or inhibition (filled bars) of channel function was observed in iodide efflux
experiments after stimulation with CCPT  25 M. C–F, effects on channel
function described in literature for iodide influx in FRT cells after stimulation
with 0.1M forskolin (C) (93), short-circuit current measurements in the pres-
ence of 5 M (D), or 100 M CPT-cAMP (E) (62) or patch clampmeasurements
in excised patches after stimulation with 0.05 M forskolin (F) (94). Symbols
have the samemeaning as in B. Data obtained from biological duplicates are
shown with standard deviations.
FIGURE 9. A and B. Effects of capsaicin on ECAR in comparison with pub-
lished results on channel function. A, ECAR as a function of capsaicin con-
centration in CHO K1 () in the presence of 50 M CPT-cAMP and CHO-CFTR
cells in the presence of CCPT 50M (f), CCPT 25M (	), or CCPT 5M (*).
B, concentration range reported to causepotentiationby capsaicinwhole cell
patch clamp experiments in the presence of 10 M forskolin (95). Data
obtained from biological duplicates are shown with standard deviations.
Titration curves are fitted with Equation 4.
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efflux (VI  27.9 fmol cell1 min1). The highest CPT-cAMP
concentration measured (CCPT  1 mM) yielded similar
although a slightly lower iodide efflux value, suggesting a sec-
ond plateau. As the experiment at CCPT  1 mM was not fully
reversible, the value was not included in Fig. 11A.
Fig. 11B shows an analogous plot for forskolin. The iodide
efflux increased with forskolin concentration up to a first pla-
teau (VI 18.9 fmol cell1 min1) in the concentration range
Cfsk  3–10 M. A concentration of Cfsk  10 M is generally
used (9) to obtain full CFTR phosphorylation. At higher con-
centrations, again a distinct increase in iodide efflux was
observed which lead to a second plateau (VI25.6 fmol cell1
min1).
It is interesting to note that iodide efflux increased with the
concentration of both phosphorylation agents, first in an ATP-
dependent manner up to similar iodide efflux values of 18
fmol min1 cell1 (first plateau in Fig. 11, A and B) and second
by anATP-independentmanner again up to comparable values
(second plateau in Fig. 11).Whereas the first plateau is reached
at full phosphorylation of CFTR, the second ATP-independent
increase in iodide efflux (see also Fig. 12) can be explained by
the modulatory (ATPase inhibitory) effect of phosphorylation
agents. The potentially small decrease in iodide efflux at the
highest concentrations of phosphorylation agents (CCPT  1
mM see text and Cfsk 100 M, see Fig. 11B) was rather due to
a general metabolic effect than to specific inhibitory phosphor-
ylation sites in CFTR (69).
Iodide Efflux at Different Concentrations of Chloride Channel
Inhibitors and Potentiators—Iodide efflux experiments in the
presence of chloride channel inhibitors and activators were
again performed under conditions closely resembling those in
microphysiometry, i.e. cells were pre-incubated with CPT-
cAMP and were then titrated with the compound of interest.
Because higher CPT-cAMP concentrations (CCPT 50 M)
strongly enhanced iodide efflux, and lead to a complete iodide
efflux from cells within 3 min or less, efflux experiments with
chloride channel inhibitors and potentiators were performed
with lower CPT-cAMP concentrations. In the presence of
CPT-cAMP (CCPT 25 M), glibenclamide (Cglib 2–50 M)
(Fig. 5D), glipizide (Cglipz 1–20 M) (Fig. 6C), and CFTRinh-
172 (Cinh172 0.1–1M) (Fig. 7D) did not potentiate CFTR-de-
pendent iodide efflux in CHO-CFTR cells. Conversely, genis-
tein (Cgen10 M) distinctly increased iodide efflux under the
same conditions (Fig. 8C).
As seen from literature data included in the legends to Figs.
5–7, chloride channel inhibitors reduce anion channel activity
already in the lower concentration rangewhereATPase activity
increased and reached a maximum. Inhibition persisted at
higher concentrations, where ATPase activity decreased again.
In the low concentration rangewhereATPase activity was high,
occlusion of the channel is most likely the result of a dynamic
process (see “Discussion”). In the high concentration range,
occlusion can be explained in terms of the two-site binding
model (Equation 4) andmost likely results from “static” channel
occlusion by inhibitors as described previously (70). As many
FIGURE 10.A and B. Effects of CPT-cAMP and forskolin on iodide efflux of
CHO-CFTR cells. CHO-CFTR cells were loaded with sodium iodide, and the
recorded efflux rateswere plotted against time.Horizontal bars indicate stim-
ulationwith 50M (*), 100M (E), 200M (f), and400M (ƒ) CPT-cAMP (A) or
with 0.5 M (*), 5 M (E) and 10 M (f) forskolin (B).
FIGURE 11.A andB.Maximum iodide efflux per CHO-CFTR cell as a func-
tion of the concentration of phosphorylation agents. A, stimulation
with CPT-cAMP (f). B, stimulation with forskolin (Œ). Error bars represent
the standard deviation of three experiments. Dotted lines were added to
guide the eye.
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CFTR chloride channel inhibitors are anionic amphiphiles,
inhibition may be enhanced by repulsive electrostatic
interactions.
Conversely, chloride channel potentiators barely enhanced
the ATPase activity of CFTR at low concentrations, in agree-
ment with previous investigations (71), and even reduced it at
higher concentrations. At the highest concentrations the
potentiators also inhibited chloride flux (62) by channel occlu-
sion, most likely again due tomore than onemolecule bound to
the TMDs.
Contribution of Adenylate Cyclase Activity—Whereas CPT-
cAMP directly interacts with PKA, forskolin stimulates cAMP
synthesis from ATP by activating adenylate cyclase. Because
adenylate cyclase activity (72) and phospho group transferase
activity of PKA (73) both work in the time frame of minutes,
experimental differentiation between the two processes was
not possible. To solve this problem, we compared theATP con-
sumed to induce a given iodide effluxwith eitherCPT-cAMPor
forskolin. As seen in Fig. 12, the ATP hydrolysis rates required
for a given iodide flux were identical at low concentrations of
phosphorylation agents. However, at higher forskolin concen-
trations (Cfsk 1 M), the ATP hydrolysis rate significantly
increased and was clearly higher than in the presence of CPT-
cAMP. The higher energy cost in the presence of forskolin can
be attributed to the activity of adenylate cyclase.
Estimating CFTR-mediated Iodide Efflux from Loaded
Cells—The present data allow a crude estimate of the iodide
molecules passing through CFTR per ATP hydrolyzed. If we
assume that the catalytic rate constant of the CFTR-ATPase in
the presence of high concentrations of CPT-cAMP is on the
order of 1% of the total CFTR-related ATP hydrolysis rate
(kcat, CFTR1ATP s1) and that, under these conditions, iodide
efflux is 30 fmol min1 cell1, the number of iodide mole-
cules flowing out of the iodide-loaded cells through CFTR was
estimated as n104 s1. This number is lower than the average
number (n 106 s1) estimated by patch clamp experiments
(74). Nevertheless, the data show that the number of anions
passing through the channel during one catalytic cycle is high.
Discussion
Here, we provide a detailed analysis of the CFTR-
ATPase activity andCFTRphosphorylation byPKA in live cells,
using the ECAR andOCR as a proxy for the ATP consumption/
hydrolysis rate. In the unperturbed cellular environment, the
different ATP-consuming processes could be measured with a
good signal to noise ratio that allowed unraveling their influ-
ence on CFTR channel gating in an unambiguous manner.
Taken together, these results lead to a new model for the cata-
lytic cycle of CFTR.
CFTR Phosphorylation, CFTR-ATPase Activity, and Anion
Flux—First, we showed that the totalCFTR-relatedATPhydro-
lysis rate (or total, apparent catalytic rate constant) in the pres-
ence of CPT-cAMP was kcat, app  140 s1. The major contri-
bution (90%) was due to phosphorylation of the
approximately 10 serine residues in the R-domain of CFTR. If
phosphorylation was stimulated with forskolin, the rate of ATP
hydrolysis was even higher, because adenylate cyclase also
contributed (Fig. 12).
The catalytic rate constant of the partially phosphorylated
CFTR-ATPase was determined as kcat, CFTR	14 s1. Whether
ATPase activity increased (16), stayed constant (75), or even
decreased with increasing phosphorylation was at first sight
difficult to decide, because of the lowbasal activity of theCFTR-
ATPase compared with the activity of PKA. The good fit of
Equation 3 to PKA activity in Figs. 2A and 4A supports a con-
stant CFTR-ATPase activity. However, data summarized in
Table 3 show that CPT-cAMP and forskolin act as modulators
in combination with other compounds. The modulator-in-
duced CFTR-ATPase activity showed bell-shaped dependence
on concentration and decreased at high concentrations.
Second, we showed that the ATPase-incompetent mutation,
CFTR-E1371S, cannot be phosphorylated, suggesting that
phosphorylation occurs only if the post-hydrolysis transition
state can been reached. Although CFTR-ATPase activity was
required for phosphorylation, it was not required for anion flux
through CFTR-E1371S, most likely because the mutation as
such influences the stability of the protein (76) and may open
the ion channel constitutively as shown for a related mutation
CFTR-E1371Q (77).
Third, we demonstrated that the ATPase activity of phos-
phorylated CFTR could be greatly enhanced with anion chan-
nel inhibitors but not with anion channel potentiators. The lat-
ter rather reduced the ATPase activity of CFTR and, as a side
effect, induced a shift from glycolysis to cellular respiration.
Iodide efflux increased with the concentration of phosphor-
ylation agents and reached a first plateau at complete phosphor-
ylation (Fig. 11). Interestingly, further addition of phosphoryla-
tion agents led to a further increase in anion efflux without
FIGURE 12. Total CFTR-related ATP hydrolysis rate versus maximum
iodide efflux. The total CFTR-related ATP synthesis/hydrolysis rate was
derived from ECAR and OCR measurements at superfusion with phosphory-
lation agents for 6 min to approximate the time frame of iodide efflux mea-
surements more closely. Iodide efflux increased with the total CFTR-related
ATPhydrolysis rateup toa certain value in thepresenceofbothCPT-cAMP (f)
and forskolin (E). At high concentrations of bothphosphorylation agents, the
iodide efflux increased in an ATP-independent manner. The amount of ATP
required for a given iodide efflux was significantly higher upon phosphoryla-
tionwith forskolin thanuponphosphorylationwithCPT-cAMP. Because it can
be assumed that PKA and CFTR require the same amount of ATP under both
conditions, the surplus in ATP hydrolysis in the presence of forskolin can be
attributed to the synthesis of cAMP fromATP catalyzed by adenylate cyclase.
Dotted lineswere added to guide the eye.
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further stimulation of ATP hydrolysis (Figs. 11 and 12). This
further increase in iodide efflux can be explained by the modu-
latory (ATPase-inhibitory) effect of phosphorylation agents at
high concentrations.
NewModel for the Catalytic Cycle of CFTR—The strong sim-
ilarity between ATPase activity curves of CFTR (Figs. 5–7) and
ATPase activity curves of P-glycoprotein (59) and Sav1866 (78,
79), a bacterial homolog of P-glycoprotein, suggests that CFTR
binds and flips (or rather flops) amphiphilic compounds from
the inner to the outer membrane leaflet as the other two trans-
porters. The fact that transport by CFTR has been difficult to
observe may be due to fast diffusion of these compounds rela-
tive to transport (80). As for P-glycoprotein, CFTR binds and
transports a mixed set of allocrites, including, for example,
chloride channel inhibitors and the phosphorylation agents
CPT-cAMP and forskolin.
Because of these similarities, we tested whether amodel for the
catalytic cycle of Sav1866, based on molecular dynamics simula-
tions (81), could also be applied to CFTR. The model (Scheme 1)
assumes that the transporter remainsmoreor lessassociatedat the
NBDsduring thewhole catalytic cycle (82) and alternates between
an outward closed conformation with two identical nucleotides
bound (e.g. twoATPs or twoADPs) and an outward open confor-
mation, inducedbyATPhydrolysis at a single site.Thismodel is in
contrast to previous models (see Introduction); however, it is in
agreement with the recent investigation of the accessibility of cys-
teines in CFTR’s TMDs by cysteine-reactive probes (34), and it
also agrees with the finding that addition of ADP at higher (milli-
molar) concentrations closes the anion channel of CFTR (83),
most likely due to binding of two ADPs.
The fact that hydrolysis was required for phosphorylation to
occur pointed to the relevance of the post-hydrolysis transition
state.We therefore assumed that the post-hydrolysis transition
state corresponds to the open state of the anion channel. The
assumption is consistent with previous measurements in
inside-out membrane patches showing that efficient stabiliza-
tion of the open channel was achieved by orthovanadate,
known to bind to the post-hydrolysis transition state (84–86).
Moreover, it is supported by the observation that non-hydro-
lyzable ATP analogs do not open (83) CFTR.
Here, we demonstrated that highly ATPase-activating com-
pounds act as chloride channel inhibitors at low and interme-
diate concentrations (see activating branch of the ATPase
activity curve in Figs. 5–7). Inhibition of anion flux occursmost
likely, because the dwell time in the outward open confor-
mation (i.e. post-hydrolysis transition state) is short com-
pared with the dwell time in the closed conformation. Mech-
anistically this dynamically closed “state” differs from the
occluded state described previously (70). The occluded state
is consistent with conditions found at high concentrations of
chloride channel inhibitors (i.e. decreasing branch of the
ATPase activity curve) where most likely more than one
molecule is bound to CFTR.
Hence, to obtain significant anion flux, consisting of 104
s1, the post-hydrolysis transition state has to be stabilized.We
suggest that the role of the highly negatively charged phosphor-
ylated R-domain is to delay nucleotide exchange in the post-hy-
drolysis transition state and to thereby prolong channel open
time. An analogous phosphorylation-dependent slowdown in
activity was observed for Rap1 (87).
The open state can also be prolonged by binding of potenti-
ators that reduce the ATPase activity and slow down flopping
and drug release (rate constant k2). As shown for P-glycopro-
tein, drug release is rate-determining (88).
Upon exchange of ADP at NBD2 for ATP, which leads to a
state where two ATPs are bound to the NBDs, the TMDs close
at the extracellular side and thereby squeeze out the com-
pounds that have not yet left the cavity toward the extracellular
lipid leaflet. At this point the catalytic cycle can restart.
With the present analysis, we demonstrated that measuring
the CFTR-related ATP hydrolysis rate in live cells is comple-
mentary to electrophysiological measurements of CFTR.
Together, the different types of techniques provided a coherent
view of the complex interplay between CFTR phosphorylation,
CFTR-ATPase activity, and anion channel gating.
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SCHEME1.Schemeproposed for the catalytic cycleofCFTR.CFTRwith two
molecules of ATP bound (CFTR(ATP/ATP)) corresponds to the outward closed
conformation (81). In this conformationadrug,D (e.g. chloride channelpoten-
tiator or inhibitor), can enter the cavity from the cytosolic leaflet of the mem-
brane. Uponhydrolysis and release of inorganic phosphate, Pi, the post-hydroly-
sis transition state of CFTR is reached (CFTR(D)(ATP/ADP)). The post-hydrolysis
transition state corresponds to the outward open conformation that allows for
anion flux through CFTR. In cells the post-hydrolysis transition state is stabilized
by the R-domain that adopts a net negative charge upon phosphorylation as
indicatedbythe redcircle. Thehighnetnegativecharge inthevicinityof theNBDs
may prevent nucleotide exchange by electrostatic repulsion and may delay
anion channel closing. CFTR with an empty NBD2 (CFTR(ATP/) is still open but
short lived. The rate constant, k1, includes drug, D, binding from the lipid mem-
brane to the TMDsof CFTR and release of inorganic phosphate uponATPhydro-
lysis. The rateconstant, k2, includesdrug transportor floppingand release,which
may be rate-limiting (36, 45) as well as ADP release. The rate constant, k3, corre-
sponds toATPbindingandconcomitant squeeze-outof thedrug,D, thathasnot
left the transporter cavity before. The apo-conformation was not considered,
because the cellular ATP concentration is typically CATP 1–10mM (96, 97), and
theconcentrationofhalf-maximumactivationofCFTRbyATPwasdeterminedas
K0.550M for CFTR (27).
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